MDNA213

N/A

Report date: 2023/09/01 17:36:31

Base Information

Drug NameMDNA213
Drug Alias NameMDNA213MDNA-213
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-2 replacementsNatural killer cells stimulantsT lymphocytes stimulants +[4] 
TargetsInterleukin-13 receptor subunit alpha-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesMedicenna Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A